Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
745.95 | -47,08% | -25,37% | 671.926,47 | 0,69% | 3,59% |
|
NasdaqGS:COST
Costco Wholesale
|
711.25 | 0% | 0% | 315.442,25 | 0,57% | 15,66% |
|
NYSE:ABBV
AbbVie
|
164.66 | -22,19% | -11,9% | 291.554,73 | 3,77% | 7,24% |
|
LSE:AZN
AstraZeneca PLC
|
109.14 | 31,94% | 57,16% | 169.192,22 | 2,1% | 15,59% |
|
NYSE:ABT
Abbott Laboratories
|
105.27 | 1,28% | 13,88% | 182.662,85 | 2,08% | 9,04% |
|
NYSE:DHR
Danaher
|
236.36 | -12,57% | -0,96% | 175.035,03 | 0,44% | 12,65% |
|
NasdaqGS:AMGN
Amgen
|
262.75 | 4,35% | 14,82% | 140.932,68 | 3,41% | 5,31% |
|
NYSE:DE
Deere &
|
400.60 | 18,09% | 27,23% | 111.510,3 | 1,48% | 29,87% |
|
NYSE:BMY
Bristol-Myers Squibb
|
48.30 | 47,47% | 56,89% | 97.892,45 | 5,02% | 13,54% |
|
ASX:CSL
CSL
|
271.40 | 26,48% | 48,09% | 131.154,79 | 1,35% | 7,18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
66.16 | 23,82% | 33,33% | 82.499,49 | 4,6% | 0,15% |
|
NYSE:CL
Colgate-Palmolive Co
|
86.71 | -3,12% | 7,41% | 71.274,43 | 2,31% | 1,57% |
|
NYSE:BDX
Becton Dickinson and Co
|
233.15 | 17% | 31,32% | 67.357,56 | 1,64% | 2,09% |
|
XTRA:BAS
BASF
|
51.07 | 11,75% | 37,12% | 45.581,11 | 6,67% | -13,88% |
|
NYSE:DOW
Dow
|
56.49 | -1,26% | 30,61% | 39.727,62 | 4,93% | -11,15% |
|
SWX:GIVN
Givaudan
|
3902.00 | 5,66% | 16,81% | 36.004,73 | 1,75% | 5,88% |
|
SWX:ALC
Alcon
|
72.12 | 22,09% | 39,24% | 35.572,79 | 0,33% | 5,47% |
|
ENXTPA:SGO
Compagnie de Saint-Gobain
|
71.20 | 1,24% | 11,71% | 35.746,78 | 2,95% | 16,97% |
|
NYSE:CTVA
Corteva
|
53.96 | 23,65% | 45,78% | 37.711,59 | 1,2% | 16,12% |
|
XTRA:BEI
Beiersdorf
|
135.60 | 5,13% | 16,95% | 30.756,65 | 0,75% | 3,11% |
